Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Window of Opportunity Trial: FL-101 in Non-Metastatic Muscle Invasive Bladder Cancer

NCT05395260 is registered in ClinicalTrials.gov with Flame Biosciences as lead sponsor.

NCT NCT05395260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05395260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Window of Opportunity Trial: FL-101 in Non-Metastatic Muscle Invasive Bladder Cancer
Lead sponsor
Flame Biosciences
Phase
Phase 1
Overall status
Withdrawn
Start date
August 22, 2022
Completion date
December 28, 2022
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

muscle invasive bladder carcinoma